Cleared Traditional

K223243 - BD Microtainer Contact-Activated Lancets

Also marketed or referenced as:
BD Microtainer® Quikheel™ Lancets

K223243 is the FDA 510(k) clearance for BD Microtainer Contact-Activated Lancets by Becton, Dickinson and Company. It is a Class 2 General & Plastic Surgery device (product code FMK) cleared through the Traditional 510(k) pathway after a 57-day FDA review.

K223243 · Becton, Dickinson and Company · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2022
Decision
57d
Days
Class 2
Risk

K223243 is an FDA 510(k) clearance for the BD Microtainer® Contact-Activated Lancets. Classified as Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature (product code FMK), Class II - Special Controls.

Submitted by Becton, Dickinson and Company (Franklin Lakes, US). The FDA issued a Cleared decision on December 16, 2022 after a review of 57 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4850 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Becton, Dickinson and Company devices

Submission Details

510(k) Number K223243 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 20, 2022
Decision Date December 16, 2022
Days to Decision 57 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 115d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMK Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4850
Definition A Disposable Blood Lancet Intended For A Single Use That Is Comprised Of A Single Use Blade Attached To A Solid, Non-reusable Base (including An Integral Sharps Injury Prevention Feature) That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes. The Integral Sharps Injury Prevention Feature Allows The Device To Be Used Once And Then Renders It Inoperable And Incapable Of Further Use.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - FMK Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature

All 69
Devices cleared under the same product code (FMK) and FDA review panel - the closest regulatory comparables to K223243.
Safety Lancet
K223208 · Suzhou Zhenwu Medical Co., Ltd. · Feb 2023
Safety Lancet
K222801 · Sarstedt AG & CO KG · Jan 2023
Disposable Safety Lancets
K223313 · Huaian Hening Medical Instruments Co., Ltd. · Jan 2023
Disposable Safety Lancet
K222408 · Beijing Ruicheng Medical Supplies Co., Ltd. · Nov 2022
Disposable Sterile Lancet
K222055 · Tianjin Rilifine Medical Device Co., Ltd. · Nov 2022
Unistik TinyTouch Sterile Single-Use Heel Incision Safety Lancets - Preemie and Full-Term, Unistik Heelstik Sterile Single-Use Heel Incision Safety Lancets - MicroPreemie, Preemie, Full-Term and Toddler
K222168 · Owen Mumford, Ltd. · Nov 2022